Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Source | Last Updated |
---|---|
LIPID MAPS Proteome Database (LMSD) | June 16, 2024 |
Main Class | Sub Class | LM ID | Name | LipidBank ID | KEGG ID | PubChem CID ▼ | ChEBI ID | Exact Mass | Formula |
---|---|---|---|---|---|---|---|---|---|
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EG04 |
|
44261783 | 2390.245525 | C108H191N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EG03 |
|
44261782 | 2362.214225 | C106H187N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EG02 |
|
44261781 | 2334.182925 | C104H183N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EG01 |
|
44261780 | 2306.151625 | C102H179N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EF08 |
|
44261779 | 2444.292475 | C112H197N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EF07 |
|
44261778 | 2416.261175 | C110H193N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EF06 |
|
44261777 | 2446.308125 | C112H199N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EF05 |
|
44261776 | 2418.276825 | C110H195N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EF04 |
|
44261775 | 2390.245525 | C108H191N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EF03 |
|
44261774 | 2362.214225 | C106H187N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EF02 |
|
44261773 | 2334.182925 | C104H183N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EF01 |
|
44261772 | 2306.151625 | C102H179N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EE08 |
|
44261771 | 2444.292475 | C112H197N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EE07 |
|
44261770 | 2416.261175 | C110H193N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EE06 |
|
44261769 | 2446.308125 | C112H199N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EE05 |
|
44261768 | 2418.276825 | C110H195N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EE04 |
|
44261767 | 2390.245525 | C108H191N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EE03 |
|
44261766 | 2362.214225 | C106H187N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EE02 |
|
44261765 | 2334.182925 | C104H183N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EE01 |
|
44261764 | 2306.151625 | C102H179N5O52 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505ED08 |
|
44261763 | 2565.318751 | C116H204N4O57 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505ED07 |
|
44261762 | 2537.287451 | C114H200N4O57 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505ED06 |
|
44261761 | 2567.334401 | C116H206N4O57 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505ED05 |
|
44261760 | 2539.303101 | C114H202N4O57 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505ED04 |
|
44261759 | 2511.271801 | C112H198N4O57 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024